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and implementation results. RESULTS: Outpatient hemophilia treatment is 
covered by health insurance schemes in more than 80% of the selected cities, yet 
with reimbursement caps and patient co-pay requirements. While there is 
significant variation by city, the average co-pay requirement is more than 50% 
and annual reimbursement is usually capped below USD16k (100k CNY). 
However, some cities have pioneered innovative policies to provide better 
coverage for hemophilia patients: Guangzhou health insurance bureau has 
decreased hemophilia co-payments to less than 10% after their extensive review 
of the economics of hemophilia treatment. The local health insurance bureau in 
Qingdao has decided to joint-fund prophylaxis treatment for pediatric patients 
together with a FVIII manufacturer. CONCLUSIONS: Hemophilia treatment 
reimbursement in China is still at a low level overall despite a few pioneer cities 
which have identified unique approaches to reducing the economic burden of 
patients living with hemophilia. There is significant room to increase 
reimbursement ratio and cap to reduce patients’ economic burden, and 
meanwhile we expect tailored public-private partnerships to be a promising 
supplementing solution.  
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OBJECTIVES: In the Brazilian public health care system, the government 
establishes one value to reimburse the entire country for the use of different 
health care facilities. In the supplementary/private system, as a business-to-
business negotiation, each the hospital negotiates different reimbursement 
values with each payer for the use of distinct hospital facilities. There are eight 
different types of hospital facilities available in the supplementary system: 
standard, cardiovascular unit, surgery unit, psychiatric, day hospital, nursery, 
adult and pediatric ICU. The objective of this study is to find out and compare 
hospital facilities daily reimbursement values and establish a mean 
reimbursement value for each facility type in the private health care. METHODS: 
Data was obtained from BI.2iM database, a 5 million people sample of the 
Brazilian supplementary health care market. All values are in 2009 Brazilian reais 
(US$1.00 = R$ 2.00). Data are presented as mean±standard deviation RESULTS: 
65% of the patients are from medical cooperatives, HMOs 20%, self-management 
11%, others 4%. A total of 303,573 hospitalizations were reviewed with a total 
expenditure of R$ 82.9 million. The mean reimbursement for each facility type 
was: standard R$ 152.43±R$ 148.80; cardiovascular unit R$ 183.03±R$ 92.63; 
surgery unit R$ 202.06±R$ 87.74; psychiatric R$ 121.42±R$ 50.66; day hospital R$ 
79.60±R$ 23.50; nursery R$ 73.25±R$ 30.67; adult ICU R$ 625.82±R$ 305.71 and 
pediatric ICU R$ 762.91±R$ 330.58. CONCLUSIONS: There is not a single 
reimbursement list (health plans to the providers) or fixed values for hospital 
facilities daily reimbursement values. We found different mean values of 
hospital facilities daily reimbursement that vary according to the facility type. 
Even within the same facility type there is also reimbursement value variation.  
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OBJECTIVES: The large variation in payments hospitals receive for similar 
services has captured the attention of payers and policy-makers looking for ways 
to curb excess health care spending. There is little empirical evidence regarding 
the specific role that patient, population, and market factors might have in 
driving price variation across small geographic areas and how these factors vary 
by payer. The purposes of this study are: (1) to provide insight into the 
relationship between patient, population, and market factors and payer-specific 
prices for several common conditions, and (2) to examine the factors that 
influence differences in the inpatient price per discharge between public 
(Medicare) and private payers among different hospital services. METHODS: We 
extracted hospital data from six states where a Healthcare Cost and Utilization 
Project (HCUP) price-to-charge ratio (PCR) was available from the 2006 State 
Inpatient Databases (SID). Even in states with PCR data, the PCR was not 
available for Kaiser Permanente hospitals so those discharges were excluded. 
The price per discharge was measured at the county-level for all discharges, an 
acute condition (acute myocardial infarction), and an elective condition (knee 
arthroplasty). Payer-specific inpatient prices were estimated by applying the 
HCUP PCR to total hospital charges. Ordinary least squares regression models 
were used to identify factors significantly associated with inpatient price per 
discharge by payer. RESULTS: Hospitals charged significantly higher prices to 
private payers compared to public payers. There was more variation in price per 
discharge for private payers compared to public payers for most hospital 
services. Specific market factors, including hospital competition, were associated 
with the price variation between payers. CONCLUSIONS: The larger variation in 
the price per discharge identified among private payers necessitates further 
exploration. It may stem from differences in negotiated prices and market power 
across small geographic areas, or the price restraints of public payers.  
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OBJECTIVES: To understand IVF policy landscape, reimbursement and access to 
treatment in the global health markets, and trends and drivers of change, for the 
purpose of identifying markets likely to support reproductive health franchises. 
METHODS: IVF ecosystems were assessed in 19 countries. We conducted a 
thorough review of published literature pertaining to Assisted Reproductive 
Technology (ART) policy, reviewed infertility organization and clinic websites 
and associated publications. Key market differences impacting the IVF 
environment were identified and analyzed for comparison. RESULTS: 
Opportunities in IVF must consider reimbursement policy, cultural influences, 
and med-tourism. While the US is one of the most advanced markets with 
respect to number of IVF cycles, technologies utilized, and cultural trends, 
healthplans provide no reimbursement and most patients pay 100% out-of-
pocket (OOP). Elsewhere, reimbursement varies greatly: Israel and European 
countries tend to provide more generous reimbursement than Latin America and 
Africa, however restrictions and requirements can greatly limit the coverage. 
Recent legislation changes in European markets have expanded reimbursement, 
and changes in South America are likely to evolve as reproductive health 
awareness and access to infertility treatment becomes more widespread. Finally, 
many patients do seek treatment abroad due to lower costs, shorter waitlists, 
and fewer restrictions: South America, South Africa, and Israel tend to be sought 
after destinations for patients willing to pay OOP. CONCLUSIONS: Reproductive 
health is unlike other therapeutic areas because reimbursement, alone, is 
insufficient to assess opportunity. Given the breadth of this poorly reimbursed 
therapeutic area, stakeholders must seek to appreciate the impact of cultural 
trends and med-tourism, including: declining birth rates, increasing access to 
IVF and reproductive health awareness, improvements in local economies and 
reforms to public policy. Manufacturers and policy makers should prepare to 
understand evolving market access and patient environments to effectively 
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OBJECTIVES: Quantify adoption patterns of quality improvement (QI) 
interventions designed to support evidence-based guidelines for hospital-
acquired pressure ulcer (HAPU) prevention. METHODS: We surveyed wound care 
nurses at 180 University HealthSystem Consortium (UHC) hospitals to determine 
which QI interventions were included in HAPU prevention protocols. The 
validated questionnaire organized 29 HAPU-specific QI interventions into four 
domains: Leadership; Staff; Information Technology (IT); and Performance & 
Improvement (P&I). Respondents checked QI interventions implemented 
anytime between 2007-2012. Descriptive statistics evaluated patterns of QI 
adoption and t-tests established statistically significant (p>0.05) increases in 
adoption. The points of time evaluated for QI adoption were 3rd-quarter, 2008 
when changes to Medicare policy discontinued HAPU reimbursement, and 2nd-
quarter, 2012. Increases were described in terms of scope (number of QI domains 
employed) and scale (number of QI interventions within domains). RESULTS: 
Fifty-five (30.6%) hospitals responded to the survey. Fifty-three (96%) hospitals 
implemented QI with HAPU prevention. Leadership interventions were most 
frequent, increasing in scope from 40-63% between 2008-2012; scale increased 
significantly for all leadership interventions, with “annual programs to promote 
pressure ulcer prevention” showing the greatest increase. Staff interventions 
increased in scope from 32-53%; signficant increases in scale occurred for six-of-
seven interventions, with “frequent consult driven huddles” undergoing the 
greatest increase. IT interventions increased in scope from 31-55%, and all five IT 
interventions increased significantly. Establishing an electronic HAPU 
trigger/alarm for high-risk patients accounted for the greatest adoption. P&I 
interventions increased in scope from 18-40%. Seven-of-nine P&I interventions 
had significant increases in scale, with “new skin care products…” increasing the 
most. CONCLUSIONS: UHC hospitals increased adoption of QI interventions, 
including scope and scale of QI strategies, since changes in Medicare policy to 
support HAPU prevention protocols and make use of novel technology and 
medical products. The next step in this research is to compare the effectiveness 
of different QI interventions.  
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OBJECTIVES: Due to emerging health care crisis of nationwide sharp decline in 
family physician (FP) supply, this study investigates the relationship between the 
supply of local FP workforce and the general population health status in the US 
federal regions. METHODS: A cross-sectional study was performed by merging 
the individual-level data from the 2009 Behavioral Risk Factor Surveillance 
System (BRFSS) with the county-level data from the 2011-2012 Area Resource File 
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(N=401,269). Multivariate logistic regression was used to predict the self-reported 
health status (binary: 1=better than good; 0=fair or poor) using the number of FPs 
per 1,000 population in each county and controlling for individual socio-
demographics. Stratified analyses were performed across US federal regions 
(Northeast, Midwest, South and West). RESULTS: The mean age of the study 
population was about 57 years with 38% being female. Findings suggested that 
increasing local family physicians supply was significantly and positively 
associated with the general health status at national level (adjusted odds ratio 
[AOR=1.096; 95% confidence interval [CI], 1.075-1.118]). Similar results were found 
in different federal regions with some regional variations (Northeast, AOR=1.087, 
95% CI, 1.033-1.144; Midwest, AOR=1.022, 95% CI, 0.976-1.070; South, AOR=1.091, 
95% CI, 1.055-1.128; West, AOR=1.045, 95% CI, 1.002-1.088). For individual level 
variables, health status was positively associated with greater amount of 
physicial activities (AOR=2.424, 95% CI, 2.375-2.474) and, was negatively 
associated with smoking habits (current smoker vs non-smoker: AOR=0.557, 95% 
CI, 0.532-0.583). CONCLUSIONS: Family physicians assume a key role in the 
frontline of the US public health system promoting public health awareness and 
education. Our findings indicate that FP supply shortage may be associated with 
decreased population health status and the impact was greater in the Northeast 
and Southern federal regions in the US. Future studies on investigating the 




PREDICTORS OF INPATIENT ADMISSION FOLLOWING OPIOID ANALGESIC 
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OBJECTIVES: We sought to estimate clinical and demographic predictors of 
inpatient admission following an opioid abuse-related emergency department 
(ED) visit in the United States. METHODS: Data for these analyses were derived 
from the 2006–2008 Healthcare Cost and Utilization Project’s Nationwide 
Emergency Departments Sample (HCUP-NEDS). We identified events and charges 
assigned opioid abuse, dependence, or poisoning ICD-9-CM codes – 304.0X, 
304.7X, 305.5X, 965.00, 965.02, and 965.09. Logistic regression was used to 
compute the likelihood of inpatient admission in the same hospital following an 
opioid abuse-related ED visit, adjusting for age, gender, patient residence county 
classification, US Census region, primary payer, number of comorbidities, 
presence of specific comorbidity groups (e.g., liver disease, heart disease, etc.), 
and income quartile for ZIP code. RESULTS: After adjusting for geographic 
location and specific comorbidities, factors that were significantly (p < 0.01) 
positively associated with the likelihood of inpatient admission include: number 
of comorbidities (OR=1.68; 95% CI: 1.63-1.73); privately insured (OR=1.15; 95% CI: 
1.05-1.25) and patients covered by other payers (like Worker’s Compensation, 
CHAMPUS, CHAMPVA, Title V) (OR=1.67; 95% CI: 1.43-1.95) as compared to 
Medicare patients. Factors that were significantly (p < 0.01) negatively associated 
with the likelihood of inpatient admission include: increasing age (OR=0.996; 95% 
CI: 0.994-0.998); being female (OR=0.83; 95% CI: 0.79-0.87); being uninsured (self-
pay) as compared to being covered by Medicare (OR=0.79; 95% CI: 0.69-0.89). 
CONCLUSIONS: These data provide evidence that comorbid conditions 
contribute substantially to the likelihood of inpatient admission following ED 
visit for opioid abuse or misuse. Emphasizing appropriate use of opioid 
medications may help reduce the clinical and economic burden due to adverse 
events in the setting of appropriate use.  
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OBJECTIVES: The National Cholesterol Education Program advices adults over 
age of nineteen to have their blood cholesterol checked every five years. The 
study aimed to exam the impact of sociodemographic factors to blood 
cholesterol screening. METHODS: This study conducted a cross-sectional 
secondary data analysis using 2009 Medical Expenditures panel Survey (MEPS). 
Study sample consisted of US. civilian, non-institutionalized adults who reported 
having high blood cholesterol. Cholesterol screening identified by patient’s self-
report. A series of descriptive statistics and weighted logistic regression analyses 
were used to evaluate the effect of sociodemographics (age, gender, race, 
ethnicity, insurance status, health status, smoking, metropolitan area, marital 
status, and body type) on cholesterol screening. SAS 9.2 statistical software was 
used for all analyses including sample weights and standard errors adjustments. 
RESULTS: Approximately 71 million patients reported having high blood 
cholesterol in 2009. 5.8 million (8.17 %) reported screening for blood cholesterol 
at least once in the past three years. Most of the respondents that reported not to 
have blood cholesterol screening were females (60%). Black were 54% more likely 
than White not to have blood cholesterol screening (OR: 1.542, 95% CI: 1.094-
1.57). Moreover being uninsured increase the lack of cholesterol screening twice 
as much than someone insured (OR: 2.027, 95% CI: 1.151-3.570). There were no 
significant differences in age, ethnicity, reported health status, metropolitan 
area, smoking, marital status, and body type (P>0.001). CONCLUSIONS: The study 
found a significant race difference in the report of blood cholesterol screening. 
Also insurance status was another factor in blood cholesterol screening. Increase 
awareness of cholesterol screening for minority groups and finding inexpensive 
alternatives for cholesterol screening for uninsured would help patients utilizing 
preventive care services for blood cholesterol.  
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OBJECTIVES: To describe the Adelphi CKD Disease-Specific Programme (DSP) 
methodology, outlining the collection of patient-level data from both physicians 
and their patients. METHODS: The DSP is a real world, cross-
sectional/retrospective multinational survey conducted in France, Germany, 
Spain, UK, Canada, Australia, Turkey, Russia, Brazil and Mexico between 
September 2012 and January 2013. The DSP incorporates Physician Interviews, 
Patient Record Forms (PRFs) completed by the physicians, and Patient Self-
Completion Forms. Physicians provide data regarding current clinical practice, 
CKD history and progression, symptoms, prevalence and severity. Patients 
provide information regarding knowledge and engagement, out of pocket cost, 
quality of life (KD-QOL), general health status (EQ5D) and effects on daily / 
working life (WPAI). Eligible physicians (Nephrologists and Endocrinologists) 
provided information about 8 consecutive non-dialysis patients (stages 3 to 5) 
and 4 dialysis patients. RESULTS: A total of 420 physicians (between 30-50 per 
country) participated, providing information relating to 5040 patients. A total of 
3024 (60 %) were type 2 diabetics. In total, 2520 (50%) of patients agreed to 
participate. While patient specific results will be available from April, all 
physician interviews have been completed. Early results from the interviews in 
France, Germany, Spain and UK suggest that 49.2% of patients were referred 
directly by PCPs, though many (59.7%) are not referred until late stage disease 
(stage 3b to 5). Only 9.4% of patients were presenting directly to the interviewee 
specialist. CONCLUSIONS: This multinational survey is providing a unique 
insight into the continuum of care of CKD patients from pre-dialysis to dialysis 
in both emerging and developed countries. While dialysis registries exist in some 
of these countries, there are limited data on real world experience of CKD in 
non-dialysis patients in particular.  
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OBJECTIVES: Patients with dementia may be at risk for more and longer hospital 
stays than those without dementia; requiring disease management. We explore 
the association between time to subsequent hospitalizations from the index 
hospitalizations for our dementia and nondementia groups. METHODS: We used 
administrative claims from 2000-2008 from a large integrated managed care 
system. Patients with any dementia diagnosis claim in any year were selected. 
From the remainder of patients a matched (on co-morbidities associated with 
dementia) group of patients of equal size without a dementia diagnosis were 
selected. The first hospitalization was the index date. We used the hospital 
claims to compare time to the next hospitalization after the index date for the 
dementia and non dementia groups. Analysis was with bivariate and 
multivariate Cox proportional hazards models controlling for demographics and 
socioeconomics characteristics and co-morbidities. RESULTS: There were 94,874 
patients with 60,869 from the dementia and 34,005 from the nondementia 
groups. The hospitalized dementia group was significantly older (81.2 vs 75.4 
years respectively p<0.001). Dementia patients had a significantly longer length 
of stay (5.4 days, SD=7.93) and more hospitalizations than non-dementia patients 
(4.8 days; SD=8.17) (p<0.0001). The Kaplan Meier curve showed that dementia 
patients had a significantly shorter time between the index and additional 
hospitalizations (logrank test, p<0.0001). Age, gender, and most co-morbidities 
significantly affect time to hospitalizations (p<0.0001). Increasing age by 1 year 
increases the relative risk (RR) of hospitalizations by 0.3%. Being female 
decreases the RR of hospitalization by 6.9%. Diabetes, CHF, and hypertension 
increase the RR of hospitalizations by 20.1%, 19.4% and 16.0% respectively. 
CONCLUSIONS: Dementia patients had more hospitalizations than non-
dementia group and a longer time to their subsequent hospitalizations than did 
the non-dementia group, even when controlling for other factors. Disease 
management might be used to improve the time between and number of 
hospitalizations for dementia patients.  
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IMPACT OF PLACE OF DELIVERY ON NEONATAL MORTALITY IN RURAL 
TANZANIA  
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OBJECTIVES: Studies on factors affecting neonatal mortality have rarely 
considered the impact of place of delivery on neonatal mortality. This study 
provides epidemiological information regarding the impact of place of delivery 
on neonatal deaths. METHODS: We analyzed data from the Rufiji Health and 
Demographic Surveillance System (RHDSS) in Tanzania. A total of 5124 live 
births and 166 neonatal deaths were recorded within the study period. The place 
of delivery was categorized as either in a health facility or outside, and the 
neonatal mortality rate (NMR) was calculated as the number of neonatal deaths 
per 1000 live births. Univariate and multivariate logistic regression models were 
used to assess the association between neonatal mortality and place of delivery 
and other maternal risk factors while adjusting for potential confounders. 
RESULTS: Approximately 67% (111) of neonatal deaths occurred during the first 
week of life. There were more neonatal deaths among deliveries outside health 
facilities (NMR=43.4 per 1,000 live births) than among deliveries within health 
facilities (NMR=27.0 per 1,000 live births). The overall NMR was 32.4 per 1000 live 
